Tocqueville Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $7.81K | Sell |
|
|||||
|
2023
Q3 | $8.87K | Hold |
|
|||||
|
2023
Q2 | $19.2K | Sell |
|
|||||
|
2023
Q1 | $30.9K | Hold |
|
|||||
|
2022
Q4 | $55.2K | Hold |
|
|||||
|
2022
Q3 | $86K | Hold |
|
|||||
|
2022
Q2 | $73K | Sell |
|
|||||
|
2022
Q1 | $114K | Hold |
|
|||||
|
2021
Q4 | $147K | Sell |
|
|||||
|
2021
Q3 | $221K | Sell |
|
|||||
|
2021
Q2 | $309K | Sell |
|
|||||
|
2021
Q1 | $327K | Sell |
|
|||||
|
2020
Q4 | $409K | Sell |
|
|||||
|
2020
Q3 | $354K | Sell |
|
|||||
|
2020
Q2 | $346K | Sell |
|
|||||
|
2020
Q1 | $827K | Sell |
|
|||||
|
2019
Q4 | $1.13M | Buy |
|
|||||
|
2019
Q3 | $661K | Sell |
|
|||||
|
2019
Q2 | $1.53M | Buy |
|
|||||
|
2019
Q1 | $1.35M | Buy |
|
|||||
|
2018
Q4 | $1.37M | Sell |
|
|||||
|
2018
Q3 | $12.1M | Buy |
|
|||||
|
2018
Q2 | $4.84M | Buy |
|
|||||
|
2018
Q1 | $5.89M | Sell |
|
|||||
|
2017
Q4 | $10.9M | Buy |
|
|||||
|
2017
Q3 | $4.87M | Sell |
|
|||||
|
2017
Q2 | $3.12M | Sell |
|
|||||
|
2017
Q1 | $2.03M | Buy |
|
|||||
|
2016
Q4 | $755K | Buy |
|
|||||
|
2016
Q3 | $960K | Sell |
|
|||||
|
2016
Q2 | $1.68M | Sell |
|
|||||
|
2016
Q1 | $1.81M | Sell |
|
|||||
|
2015
Q4 | $2.77M | Sell |
|
|||||
|
2015
Q3 | $1.72M | Sell |
|
|||||
|
2015
Q2 | $5.12M | Buy |
|
|||||
|
2015
Q1 | $6.97M | Buy |
|
|||||
|
2014
Q4 | $1.12M | Buy |
|
|||||
|
2014
Q3 | $526K | Sell |
|
|||||
|
2014
Q2 | $883K | Buy |
|
|||||
|
2014
Q1 | $848K | Buy |
|
|||||
|
2013
Q4 | $417K | Hold |
|
|||||
|
2013
Q3 | $315K | Buy |
|
|||||
|
2013
Q2 | $156K | Buy |
|